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Abstract—This paper explores interpretability tech-
niques for two of the most successful learning al-
gorithms in medical decision-making literature: deep
neural networks and random forests. We applied
these algorithms in a real-world medical dataset
containing information about patients with cancer,
where we learn models that try to predict the type
of cancer of the patient, given their set of medical
activity records.
We explored different algorithms based on neural
network architectures using long short term deep
neural networks, and random forests. Since there
is a growing need to provide decision-makers un-
derstandings about the logic of predictions of black
boxes, we also explored different techniques that
provide interpretations for these classifiers. In one of
the techniques, we intercepted some hidden layers
of these neural networks and used autoencoders
in order to learn what is the representation of the
input in the hidden layers. In another, we investigated
an interpretable model locally around the random
forest’s prediction.
Results show learning an interpretable model lo-
cally around the model’s prediction leads to a higher
understanding of why the algorithm is making some
decision. Use of local and linear model helps identify
the features used in prediction of a specific instance
or data point. We see certain distinct features used
for predictions that provide useful insights about the
type of cancer, along with features that do not gener-
alize well. In addition, the structured deep learning
approach using autoencoders provided meaningful
prediction insights, which resulted in the identifi-
cation of nonlinear clusters correspondent to the
patients’ different types of cancer.
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I. INTRODUCTION
Deep neural networks are one of the most suc-
cessful models for prediction in several different
fields, specially in medical decision-making [1], [2],
[3]. Due to its network representation and activation
functions, applications that have in their core deep
neural networks can perceive environments, extract
and learn different features that characterize the
environment, make autonomous decisions and act
based on the learnt models [4]. These network rep-
resentations together with appropriate regulariza-
tion techniques allow the incorporation of thousands
of hidden layers that contribute to extremely high
performances both in classification tasks as well as
in forecasts [5].
Although deep learning models achieve very high
discriminatory performances, their deep network
representation lacks explanatory power. It is hard for
decision-makers to understand the logic of predic-
tions of hidden layers inside deep neural networks
and obtain insights of why certain decisions were
chosen. By explanatory power, we mean models
that provide qualitative (and quantitative) inferences
about the underlying processes that support their
outputs. We have arrived to a stage where high
accuracies are no longer sufficient and there is the
need to bring together systems that can provide
explanatory mechanisms to decision-makers. It has
been acknowledged that relying on a couple of
evaluation metrics, such as accuracy, precision and
recall, is an incomplete description of most real
world tasks, and hence new metrics need to be
proposed in order to take into account the decision-
maker’s ability to interpret and understand the pre-
dictions of the deep learning algorithms [6].
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If the goal of deep learning systems is to provide
decision-making systems that can assist decision-
makers across different fields, including medical
decision-making, then one needs systems that have
underlying interpretable and explanatory mecha-
nisms that can help decision-makers trust the sys-
tem’s decisions: understand why they work, why
they failed, etc [7]. A misclassification in a patient
using a deep learning medical system can have
extremely high human costs if one blindly accepts
and trusts the system [8]. This trust can be achieved
by creating explanatory models that are able to pro-
vide interpretations of why deep learning algorithms
are making certain choices [9]. In this sense, there
is a high demand for interpretable deep learning
methods that can make the behaviour and predic-
tions of deep learning decision support systems
understandable to humans [10].
Although opaque decisions are more common in
medicine than researchers might be aware of [11],
doctors are constantly confronted with uncertainty,
and with data that is incomplete, imbalanced, het-
erogeneous, noisy, dirty, erroneous, inaccurate and
therefore there should be a moral responsibility to
provide decision-makers sufficient evidence of why
deep learning algorithms are making some predic-
tions in such complicated decision scenarios [11].
Ultimately, medical decisions should belong to the
decision-maker rather than the algorithm. The in-
formation of the algorithm should therefore comple-
ment and augment the knowledge of the decision-
maker in scenarios under uncertainty. This leads to
a dilemma in terms of the accuracy vs. interpretabil-
ity tradeoff: either we have models that achieve very
high accuracies, such as deep neural networks, but
they do not provide any understandings of how the
features interact when it comes to predictions; or
we have weaker models that provide a reasonable
interpretation of the impact different features in the
prediction process, such as decision trees, but with
much less predictive capacity [12].
Figure 1 illustrates a scenario where a model
represented by a black box is learnt by using deep
learning algorithms. As suggested by Lipton [13],
the learning algorithm should have a performance
metric that measures how well the estimator yˆ ap-
proximates to the ground truth y∗ and another metric
for interpretability, which measures the degree of
understanding of a user towards the explanations
provided by the estimated model. Ultimately, the
final decision of whether to trust or not the output of
the deep learning algorithm resides in the decision-
Fig. 1. Example of an interpretable deep learning model accord-
ing to Lipton [13]. Given an input vector x1, x2, . . . , xM , a deep
learning algorithm learns a model by approximating its estimated
prediction yˆ with the ground truth y∗. Ultimately, the decision-
maker needs to have an understanding of why the algorithm
reached certain predictions.
maker.
In medical decision support systems, predictive
tasks using deep learning approaches are hard, due
to the fact that doctors are constantly confronted
with uncertainty, and with data that is incomplete,
imbalanced, heterogeneous, noisy, dirty, erroneous,
inaccurate. This data is also expressed in arbitrarily,
and unfixed high-dimensional spaces, which makes
it hard to model it and to apply machine learning
algorithms [14], [15]. Moreover, datasets are small,
which makes the learnt models very likely to over-
fit [16].
In this paper, we investigate explainability mecha-
nisms in deep neural networks and random forests,
since these two models are have been success-
fully applied in different predictive tasks in med-
ical decision-making [17], [2]. We explore a real
world medical decision event log from the Business
Process Intelligence (BPI) Challenge1 that ran in
2011. This event log corresponds to data that was
collected in the Gynecology department from a
hospital in the Netherlands. The dataset contains
the history of all medical activities undergone by
the patient (e.g., blood test, x-rays, medical ap-
pointments, etc.), together with information about
the treatments and specific information about the
patient (e.g., age, number of years spent in treat-
ment, etc). The main challenge with this dataset is
that a patient is not defined by an N -dimensional
feature vector. Instead, a patient is defined by a set
of N features that change throughout T timesteps.
This means that patients are represented by an
unfixed length of medical activities, depending on
the severeness of their disease (e.g., a patient might
have gone through a set of 70 different medical
1https://www.win.tue.nl/bpi/doku.php?id=2011:challenge
2
activities, together with specific information about
other features, and another patient might have gone
through a set of 300 medical activities). Figure 2
shows a small example of the event log that we will
analyse in this paper.
Fig. 2. Example of an event log showing different features that
are dynamic and change through time and features that are
static.
Given that a patient is represented not by a single
N -dimensional feature vector, but by a set of T ×N
medical activities and features that change through-
out time, one can visualise the medical processes
that a single patient goes through during treatment.
In order to demonstrate the complexity of the med-
ical data that we will cover in this paper, Figure 3
shows all medical activities that a single patient who
has been diagnosed with cancer of vulva has been
through.
In this sense, we are interested in analysing
whether a set of medical activities is targeted to
a patient’s specific type of cancer. According to
Holzinger [18], health practices should be adjusted
to the individual patient and they should be reflected
in the hospitals underlying medical decision models.
The two main question addressed by this paper
are (1) to understand if patients with specific types
of cancer have a targeted and specific set of medical
activities associated to them and (2) what type of
explainability mechanisms should be involved in this
specific task to provide the user (a medical doctors,
for instance) the right information that allows the
understanding of why the algorithm is making such
predictions.
To answer these questions, we use long short
term memory (LSTM) neural networks and random
forests (RF) to make this prediction. In order to
provide explainability mechanisms to the predictions
of these models, we explore the usage of autoen-
coders, where we use these structures to intercept
hidden layers of the neural network and try to derive
interpretations of clusters that can be found in the
data. We also explore a novel explanation technique
that explains the predictions of random forests in an
interpretable and faithful manner, by learning an in-
terpretable model locally around the prediction [19].
In summary, the paper aims to contribute the
following:
1) A deep learning architecture of Long Short
Term Neural Networks for Cancer Prediction
based on real world event logs of cancer
patients
2) Investigate potential interpretations and expla-
nations of the predictions of the Long Short
Term Neural Networks using autoencoders.
3) Explore the usage of the LIME framework [19]
in the scope of event logs for medical decision
making. LIME consists in a technique that
explains the predictions of classifiers in an in-
terpretable manner, by learning an explainable
model locally around the prediction.
This paper is organised as follows. In Section II
we present the main works in the literature that
provide interpretable models for black boxes. In
Section III, we present the dataset used, how we
cleaned it and some initial understandings about the
data. In Section IV, we use deep neural networks to
predict the type of cancer of a patient given his track
of medical records. In Section IV-D, we present an
analysis where we use autoencoders to gain deeper
insights about how the predictions are being made
in the neural network. In Section V we model the
same data using random forests in order to predict
the type of cancer of the patient given the track
record of medical activities. In Section V-D, we ap-
ply a local interpretable model-agnostic explanation
technique to extract rule-based insights from the
predictions of the data. We conclude this paper in
Section VI where we summarise the main findings
in this work.
II. RELATED WORK: FROM PREDICTIONS TO
EXPLANATIONS
Over recent years, Deep Learning has demon-
strated significant impacts on several predictive
tasks in medical decision-making, ranging from
advanced decision support systems [20], [21],
[22], diagnosis of different types of cancers [23],
Alzheimer’s disease [24], [25], heart disease predic-
tion [26], diabetes diagnosis [27], etc. However, the
high performances that these algorithms achieve in
3
Fig. 3. Representing 30% of the most representative medical activities associated to a single patient diagnosed with cancer of vulva.
terms of accuracy comes at the cost of low explain-
ability and interpretability of the predicted outcomes.
Since these classifiers work by computing correla-
tions between features, and since correlation cannot
be confused with causation, a solid understanding
is required when making and explaining decisions.
Although explainable models for deep learning
are still in their infancy, there are already many
works in the literature based on different ap-
proaches that provide means to open the ”black
box” [28]. In this work, we focus in model-agnostic
methods, which are models that provide expla-
nations and interpretations that can used in any
classifier by learning an interpretable model around
the classifier’s predictions [19]. The literature in
this area can be roughly divided into two main
research streams: models based on Partial Depen-
dence Plots (PDP) and Surrogate Models (SM) [12].
Figure 4 presents an overview of the most represen-
tative model-agnostic methods in the literature.
A. Partial Dependence Plots
Partial Dependence Plots (PDP) show the
marginal effect of at most two features on the pre-
dicted outcome of a machine learning model [29].
Generally speaking, PDP approaches use Monte
Fig. 4. Most relevant model-agnostic methods proposed in the
literature.
Carlo methods to estimate partial functions by cal-
culating averages and marginal effects in the train-
ing data. This allows one to get information about
how the effect that these averages have in the pre-
diction. In Zhao & Hastie [30], the authors extended
this idea in order to incorporate causal relationships
between features and predictions. One main disad-
vantage of this approach is that it plots the average
effect of a feature in the global overall average.
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The approach also suffers from the independence
assumption and assumes that features are not cor-
related between each other. When computing the
marginals, this independence assumption can lead
to marginalizations that are not representative of the
data.
To address some of the limitations of PDP, two
algorithms were proposed: individual conditional ex-
pectation and accumulated local effects.
Individual Conditional Expectation (ICE) is a
model originally proposed by [31] and is very similar
to PDP, but with the difference that it focuses on
individual data instances, the individual conditional
expectation plots, rather than taking the overall av-
erages.
Accumulated Local Effects (ALE) Plot was origi-
nally proposed by [32] and differs from PDP by using
a small window on the features and making differ-
ences between the predictions instead of averages.
Since it is not based on comparing averages, ALE
is less susceptible to bias and is faster in terms of
performance.
There are already packages publicly available
with implementations of these algorithms. Some of
them are:
• R packages that implement PDP methods: iml,
pdp, DALEX, ICEbox.
• Python libraries that implement PDP methods:
Skater2.
B. Surrogate Models
Surrogate models are defined by starting from the
input data and the black box model by performing
several evaluations of the objective functions with
the original model [33]. In other words, they are
metamodels (or approximation models) that use
machine learning methods to approximate the pre-
dictions of a black box model, enabling a decision-
maker to draw conclusions and interpretations about
the black box [12].
The core idea underlying surrogate models is
to use basic interpretable machine learning algo-
rithms, such as linear regression and decision trees,
to learn a function using the predictions of the black
box model. This means that this regression or deci-
sion tree will learn both well classified examples,
as well as misclassified ones. Distance functions
are used to assess how close the predictions of
the surrogate model approximate the blackbox. The
2https://github.com/oracle/Skater
general algorithm for surrogate models is presented
in Algorithm II-B [12]:
Algorithm 1 General algorithm for surrogate mod-
els [12].
Input: Dataset X used to train black box, Prediction
model M
Output: Interpretable Surrogate model I
1: Get the predictions for the selected X, using the
black box model M
2: Select an interpretable model: linear model, re-
gression tree,...
3: Train interpretable model on X, obtaining model
I
4: Get predictions of interpretable model I for X
5: Measure the performance of the interpretable
model I
6: return Interpretation of I
The most representative model in the literature
that applies the surrogate formalism but to ex-
plain individual predictions is the Local Interpretable
Model-agnostic Explanations (LIME) framework pro-
posed by [19], which we will explore in this pa-
per. The main difference between LIME and Al-
gorithm II-B is that LIME focuses on training local
surrogate models to explain individual predictions.
This is done by adding a new dataset X ′ that
is a perturbation of the points in dataset X. This
allows one to see how the features change around
these points and how they affect the predictions.
The authors explored the Lasso model as the linear
interpretation model to approximate the black box.
An extension of LIME which was also proposed
by the same authors is the Anchors model [34].
The model explains individual predictions by means
of easily understandable IF-THEN rules [12], which
are called the Anchors. To find anchors, the authors
use reinforcement techniques to explore the sets of
perturbations around the data and how they affect
the predictions [35].
Another surrogate model that is inspired in game
theory is SHAP, SHapley Additive exPlanations,
originally proposed by [36]. SHAP is based on
Shapley Values, which is a type of game in game
theory that focuses in how players distribute payoffs
among each other in a fair way [37]. In this case, the
decision problem is modelled with n features that
correspond to the players and the goal is to find
a fair way to distribute the weights between each
feature. In order to compute this distribution, the
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authors proposed the KernelSHAP, which estimates
for an instance, the contributions of each feature to
the prediction. More recently, the authors proposed
another kernel, TreeSHAP, that is suitable for tree
based machine learning algorithms [38].
There are already packages publicly available
with implementations of these algorithms. Some of
them are:
• R packages that implement surrogate methods:
iml, lime, anchorsOnR,.
• Python libraries that implement surrogate meth-
ods: lime3, skater, anchor4, shap5
III. DATASET DESCRIPTION
The Dutch Academic Hospital Dataset is a pub-
licly dataset made available by the Business Pro-
cess Intelligence (BPI) challenge in 2011 by a hos-
pital in the Netherlands6. The business process
intelligence challenge is a competition where or-
ganisations make their event logs publicly available,
together with specific questions that they would like
researchers to address.
The Dutch dataset contains a set of 1142 patients
that were diagnosed with a certain type of cancer,
together with all the medical activities that they went
through in the hospital [39]. These activities are
dynamic and specific to the process of the patient
and can describe some specific urine test, in order
to try to identify potential tumours in the bladder,
tests to the heart, as well as general blood tests and
specific cancer-related treatments. The dataset not
only contains dynamic features that are connected
to the workflow of the process, but it also contains
static information, like the patient’s age, diagnosis,
etc. In total, we have some 150 291 activities cor-
responding to all the 1142 patients. Table I
The original dataset contains up to 67 features.
Many of these features had redundant informa-
tion. For instance, the diagnosis of the patient was
spread across 16 features: Diagnosis, Diagnosis:1,
Diagnosis:2, . . . , Diagnosis:15. This diagnosis at-
tribute can take values such as Squamous cell ca
cervix st IIb, which is a squamous cell carcinoma of
the cervix at stage IIb of malignancy. Associated to a
diagnosis, the dataset contains a set of 16 features
with the diagnosis code: Diagnosis Code, Diagnosis
Code:1, Diagnosis Code:2, . . . , Diagnosis Code:15
3https://github.com/marcotcr/lime
4https://github.com/marcotcr/anchor
5https://github.com/slundberg/shap
6http://www.win.tue.nl/bpi/doku.php?id=2011:challenge
Code Cancer Name # Cases
M11 Cancer of Vulva 60
M12 Cancer of Vagina (not representative) 13
M13 Cancer of Cervix 195
M14 Cancer of Corpus Uteri 95
M15 Cancer of Corpus Uteri of type Sarcoma (related to M14) 11
M16 Cancer of the Ovary 128
106 Mix of cancers: cervix, vulva, corpus uteri and vagina 113
821 Cancer of the Ovary (related to M16) 29
822 Cancer of the Cervix (uteri) (related to M13) 22
823 Mix of cancers: corpus uteri, endometrium and ovary 8
839 Mix of cancers: ovary, uterine appendages and vulva 14
TABLE I
SUMMARY OF THE DIFFERENT TYPES OF CANCER THAT CAN BE
FOUND IN THE DATASET. CODES 821, 822, 823, 839 AND M12
WERE IGNORED, SINCE THEY WERE NOT REPRESENTATIVE IN
THE DATA.
which can be one of 11 different types of cancer
that are specified in Table I. The original dataset
contains the following attributes:
• Activity: describes the medical activities that
the patient went through;
• Department: identifies the department con-
nected to the activity;
• Timestamp: record of the time that the activity
took place;
• Number of executions: number of times the
activity was performed;
• Activity code: The dataset does not provide
information about this feature;
• Producer code: The dataset does not provide
information about this feature;
• Section: The dataset does not provide informa-
tion about this feature;
• Age: age of the patient;
• Diagnosis, Diagnosis:1, . . . , Diagnosis:15:
specific diagnosis of the patient, referring to
tumours, carcinomas, metasteses, sarcomas,
etc;
• Diagnosis code, Diagnosis code:1, . . . , Di-
agnosis code:15: general code specific to a
type of cancer;
• Treatment code, Treatment code:1, . . . ,
Treatment code:10: code specific to the treat-
ment applied. The dataset does not provide
information about these codes;
• Diagnosis Treatment Combination ID, Diag-
nosis Treatment Combination ID:1, . . . , Di-
agnosis Treatment Combination ID:10: code
specific to the combination of the treatment and
the diagnosis of the patient. The dataset does
not provide information about these codes;
• Start Date, Start Date:1, . . . , Start Date:15:
start date of the activity of the patient;
• End Date, End Date:1, . . . , End Date:15: end
date of the activity of the patient;
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• Specialism code, Specialism code:1, Spe-
cialism code:2: code specific to the spe-
cialism of the diagnosis of the patient. The
dataset does not provide information about
these codes;
The data cleaning process was conducted in the
following steps:
• Missing values. The dataset contained 455
instances of patients who did not have any di-
agnosis code. The diagnosis code was spread
across 16 different features (Diagnosis, Diag-
nosis:1, . . . , Diagnosis:15). In many cases,
missing values were found in the remaining 15
features. For the cases where this information
was not available across other features, we
were able to infer the type of diagnosis based
on patients who shared similar activities and
treatment codes.
• Time features. The dataset contains 33 time
related features: tart Date, Start Date:1, . . . ,
End Date:15, End Date, End Date:1, . . . , End
Date:15 and Timestamp. The start and end
dates had a huge amount of missing informa-
tion and it was difficult to make any inferences
about the distribution of the missing data. For
that reason, we ignored these features, and
instead, we created a new feature years that
corresponds to the total amount of years a
patient was under treatment. This information
was taken by making the different between
the timestamp recorded for the first and last
activities.
• Repeated features. Features whose informa-
tion was spread around multiple features (e.g.
Treatment code, Treatment code:1, . . . , Treat-
ment code:10) were collapsed into a single
feature representing the last event recorded.
After cleaning the dataset, we ended up with 12
features: Activity, Department, Number of execu-
tions, Activity code, Producer code, Section, Age,
Diagnosis Code, Treatment code, Diagnosis Treat-
ment Combination ID and years. We analysed the
distribution and correlation of the features of the
dataset. Figure 5 show these relationships.
An initial look at the correlation map of the feature
shows that the features do not show many cor-
relations with the diagnosis code. This preliminary
analysis suggested that there can be a template set
of procedures to apply to patients that show some
potential symptoms of cancer, however it does not
seem to be any targeted set of procedures that a
Fig. 5. Correlation between features in the medical event log,
after balancing and cleaning the data.
patient goes through that is specific to a type of
cancer. This lack of correlation can already indicate
that machine learning approached might not have
very high accuracies in this specific dataset for the
task of cancer prediction.
IV. EXPERIMENT I: EXPLANATORY MECHANISMS
FOR PREDICTIONS USING DEEP NEURAL
NETWORKS
In this section, we test the hypothesis that, in
theory, patients with a specific type of cancer should
be associated to a more targeted set of medical
activities. We test this hypothesis by formulating our
problem under a deep neural network approach.
A. Problem Definition
Contrary to traditional deep learning approaches
in the literature, where a patient is defined by a
single F -dimensional feature vector, when using
event logs, we have a description of daily (or even
by hour / minutes / seconds) medical activities
associated to a patient. This means that a single
patient X(i) from a set of M patients, X(i) ∈
{X(1), X(2), . . . , X(M)}, is defined by a set of F
features that are both dynamic (showing the evolu-
tion of medical activities throughout time) and static
(features concerned with the number of years the
patient stays in the hospital). The length, T , of these
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features is also dynamic, meaning that a patient that
stays 2 years in the hospital can have records of
more than 1000 medical activities associated to him,
while another patient that spends 1 month in the
hospital can only have 20 activities in his records, for
instance. Therefore, a set of patients is represented
by a tensor with dimensions (M × L × F ) where
M corresponds to the total number of patients, L
corresponds to the length of the patient’s medical
records and D is the set of features associated
with the patients. Each patient is also associated
to a label that corresponds to the specific type
of cancer that he has been diagnosed with, Y (1),
where Y (i) ∈ {Y (1), Y (2), . . . , Y (M)}. This is the
class that we are interested in predicting.
X(1) =

f
(1)
1,1 f
(1)
1,2 . . . f
(1)
1,F
f
(1)
2,1 f
(1)
2,2 . . . f
(1)
2,F
...
...
. . .
...
f
(1)
T,1 f
(1)
T,2 . . . f
(1)
1,F )

T×F
. . .
X(M) =

f
(M)
1,1 f
(1)
1,2 . . . f
(M)
1,F
f
(M)
2,1 f
(1)
2,2 . . . f
(M)
2,F
...
...
. . .
...
f
(M)
T,1 f
(1)
T,2 . . . f
(M)
1,F )

T×F
Y =

class(1)
class(2)
...
class(M)

M×1
B. Exploring Deep Learning Architectures for Can-
cer Prediction
In the scope of this work, we analyse a trail of
medical activities and appointments associated to a
patient. This set of medical activities is recorded in
a given order, which suggests dependence between
them.
Since the nature of the data analysed in this work
is dynamic, one needs a supervised learning mech-
anism that is able to cope with data that has a strong
and meaningful dependency between features and
that is also able to keep in memory all the informa-
tion from previous time steps. For these reasons,
we opted for a Recurrent Neural network (RNN).
RNNs were originally proposed by [40] and consist
in a neural network with hidden units capable of
analysing streams of data and that has reveled to be
effective in many different applications which require
a dependency in previous computations during the
learning process, such as text classification [41],
speech [42], or even DNA sequences [43]. One
important characteristic of RNNs is that they share
the same weights across all training steps, which
is something that does not occur in traditional deep
neural network models.
In this work, we explored two different types of
Recurrent Neural Networks:
• Long Short Term Memory (LSTM) Neural
Networks: are a type of recurrent neural
networks that are particularly suitable for
applications where there are very long time
lags of unknown sizes between important
events. They provide a solution for the
vanishing and exploding gradient problems
by using memory cells [44]. These memory
cells, Ct are composed of a self recurrent
neuron together with three gates: an input
gate, it, an output gate, ot, and a forget
gate, ft. These gates are used to regulate
the amount of information that goes in / out
of the cell. Information on a new input will
be accumulated to the memory cell if it is
activated. Additionally, the past memory cell
status, Ct−1 can be forgotten if ft is activated.
The information on Ct will be propagated
to ht based on the activation of output
gate ot. Based in the activation functions, new
candidates for the memory cell, C˜, are created.
• Bidirectional Long Short Term Neural Net-
works (BiLSTM): are also a type of recurrent
neural network that connect two hidden layers
of opposite directions to the same output, which
was originally proposed by [45]. The motivation
of bidirectional neural networks is due to certain
contexts specific to datasets. It is not enough
to learn from the past to predict the future
activities, but also it should be possible to look
at the future activities in order to fix the current
predictions.
C. Predicting Patient’s Type of Cancer
In this section, we test the hypothesis that, in
theory, patients with a specific type of cancer should
be associated to a more targeted set of medical
activities. To validate this, we performed a cross
validation setting with a train/test set split of 80%
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Fig. 6. Deep neural network architecture used in our experimental setup.
/ 20% over the network architecture illustrated in
Figure 6. Table II illustrates the results obtained.
Nodes Epochs Accuracy Loss
Deep NN 25 30 0.468 1.297
LSTM NN 20 200 . 0.552 1.216
BiLSTM NN 20 150 0.517 1.230
TABLE II
RESULTS OBTAINED AFTER CONDUCTING A CROSS VALIDATION
GRID SEARCH METHOD OVER THE DISTRIBUTION OF NEURONS
AND EPOCHS USING THE ARCHITECTURE ILLUSTRATED IN
FIGURE 6. BEST RESULTS WERE FOUND WHEN USING A DEEP
LONG SHORT TERM MEMORY RECURRENT NEURAL NETWORK
DURING 200 EPOCHS AND 20 NEURONS IN THE HIDDEN LAYERS.
One major challenge with deep neural networks
is that they require a significant amount of training
data. Given that the medical dataset is small (only
1142 patients). The best results obtained were with
a Long Short Term neural network that keeps mem-
ory of previous past activities in order to predict the
type of cancer of the patients. However, due to the
lack amounts of training data, the algorithm could
not generalise well and all models found using a grid
search approach showed some levels of overfitting
as it can be seen in
D. From Predictability to Explainability using Au-
toencoders
Understanding the reasons why deep learning
algorithms make certain predictions, play an impor-
tant and fundamental role to assess the effective-
ness of the model and as well as providing new
insights of how to transform a system or a prediction
that is untrustworthy to a trustworthy one.
In this section, we investigate how the different
algorithms in Table II are classifying the patients’
cancers by using autoencoders. Autoencoders were
originally proposed by [46] and are unsupervised
learning techniques which use neural networks for
the task of representation learning. The network
architecture enables a compression of knowledge
representation of the original input. This implies
that correlated features provide a structure that can
be learned by the network and consequently one
can obtain visualisations of neurons that are being
activated in the hidden layer. This compression of
knowledge is crucial for the network architecture,
since without its presence, the network could simply
learn to copy the input values and propagate them
throughout the network [47].
The structured deep learning network that was
learnt using different layers fuses different modali-
ties of information, based not only on the patients’
track of medical activities, but also other features
such as age, time spent in treatment, etc. This
fusion of information is non-linear and leads to the
representation of one single state of knowledge.
To gain understandings about the network’s struc-
tured representation of this state of knowledge,
we intercepted the first hidden layer of both the
LSTM and BiLSTM neural networks in Figure 6 and
applied an autoencoder to learn the input that led
to the projections in this hidden layer. To be more
specific, we used an autoencoder with two dense
layers to learn the generalized latent space that
better approximates to the training data. From the
structured deep learning network, the autoencon-
ders apply a non-linear transformation in the data
that leads to a non-linear representation of clusters
that can be helpful to provide additional insights and
that can enable the investigation of misclassifica-
tions in the dataset. This provides better insights of
why the algorithm is classifying the data correctly or
incorrectly, and new understandings to the decision-
maker of
A grid search approach was used in order to find
autoencoders that could provide meaningful results
to the decision-maker regarding the relationships
between the patients features and their types of can-
cer. Figures 8 and 7 show examples of projections
that were obtained using an autoencoder with two
dense layers and different number of neurons for
the BiLSTM and LSTM layers, respectively.
After performing a grid search, we extracted
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Fig. 7. Example of grid searches over the first hidden layer of
the LSTM network for different configurations neurons in each of
the two dense layers of the autoencoder.
Fig. 8. Example of an output image from a grid search approach
that intercepts the first BiLSTM layer of the proposed deep neural
network architecture. Some clusters identifying the projections of
the types of cancer can be found
the most meaningful representations from the non-
linear projections of the autoencoders, both for
LSTM and BiLSTM network architectures, in order
to analyse the misclassifications in each model.
Figures 7 and 8, show the general latent spaces
that were extracted for the LSTM model and BiLSTM
model, respectively.
Fig. 9. Misclassifications found in the projections of the Long
Short Term Memory network with autoencoders.
Sparser results were obtained in the LSTM model,
which enabled the identification of non-linear cluster
representation in this latent space representation of
the state of knowledge of the network. As one can
see in Figure 9, one is able to find three different
clusters of data: (1) cluster 1, M16 (cancer of ovary),
(2) cluster 2, M11 and M14 (cancer of vulva and
cancer of corpus uteri), and (3) cluster 3, M13
(cancer of cervix).
In all three non-linear clusters that were identified,
one can see that patients with different types of
cancer were projected to the wrong clusters. For
instance, in cluster 1, that is identified as the cluster
with patients with cancer of ovary (M16), there are
patients that have the label cancer of vulva (M11)
and yet the model classifies not as M16, but as
M13 (cancer of cervix). This can either mean two
things, (1) this specific patient diagnosed with M11
shares a very similar track of medical activities
as a patient diagnosed with M13 or (2) the non-
linearity nature of the projections in the generalised
latent representation into a lower dimension space,
distorted the distances between these patients, and
as a consequence they were assigned to the wrong
cluster.
When it comes to diagnosis code 106, which
pertains to patients with a mix of cancers (cervix,
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vulva, corpus uteri and vagina), projections from the
general latent representation into lower dimensions
did not show specific misclassifications around this
code in that specific region of the lower dimensional
space. However, since code 106 pertains with pa-
tients with different types of cancer, which accord-
ing to the figure mainly intersects M14 (cancer of
corpus uteri), then one can understand the different
misclassifications around patients with code 106
throughout the space.
Fig. 10. Misclassifications found in the projections of the Bidi-
rectional Long Short Term Memory network with autoencoders.
On the other hand, the non-linear projections
found in the BiLSTM (Figure 10) did not show a clear
understanding when compared with the projections
in the LSTM network. This is due to the fact that
during the grid search process, no sparse represen-
tations were found, which makes the representation
of the space very compact. One can, however, still
gain insights about the misclassifications. Like it
was found in the LSTM layer, patients with cancer
of vulva (M11) were wrongly projected into the
M13 cluster (cancer of cervix). Once again, the
non-linearity of the projections, together with the
mapping into lower dimensions, disturbs the space
and the distances between the patients, leading to
misclassifications.
V. EXPERIMENT II: EXPLANATORY MECHANISMS
FOR PREDICTIONS USING RANDOM FORESTS
In this section, we explore alternative sub-
symbolic representations and understandings of
data using random forests and by learning an in-
terpretable model locally around the model’s pre-
dictions.
A. Problem Definition
The problem is converted to a classical super-
vised learning problem to compare and contrast
traditional approaches while using event logs to
predict cancer. Here, for each patient X(i), the set of
features F (both dynamic and static) are mapped to
the window of length T . The window represents the
daily (or hourly) medical activities associated to a
patient. A patient X(i) is represented by the vector:
〈f (i)1,1, f (i)1,2, . . . , f (i)1,F . . . f (i)T,1, f (i)T,2, . . . , f (i)T,F 〉. Hence, M
patients are represented by a matrix with dimen-
sions (M × (F ∗ L)). The length L is the number
of patient’s medical records (or activities recorded
for each patient). The cancer associated to each
patient is the class we predict. The advantage of this
approach is that it allows any classical supervised
machine learning algorithm to be applied.
B. Random Forests for Cancer Prediction in Event
Logs
Random forests are an ensemble method that
combine several individual classification trees [48].
A Random forest classifier uses multiple decision
tree classifiers where each decision tree classifier is
fit to a random sample, or a bootstrap sample drawn
from the original data sample. The feature selected
for each split in the classification tree is only from a
small random subset of features in each tree. Thus,
a random forest classifier consists of a number of
classification trees, the value of which is set when
identifying the model parameters. From the forest,
the class or label is predicted as an average or
majority vote of the predictions of all trees.
Random forests are known to have high prediction
accuracy as compared to individual classification
trees, because the ensemble adjusts for the over-
fitting caused by individual trees. However, the in-
terpretability of a random forest is not as straight-
forward as that of an individual tree classifier, where
the influence of a feature variable corresponds to its
position in the tree.
C. Predicting Patient’s Type of Cancer
To validate the Random forest classifier, we per-
formed a cross validation setting with a train/test set
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split of 80%/20%. The optimal parameters for the
classifier were found using grid search with k-fold
cross validation. Table III presents the accuracy for
two different parameters used during the grid search
parameter tuning. Figure 11 presents the top five im-
portant predictors. This plot shows the features such
as the Age of the patient, the type of Treatment,
and initial set of Activity performed in a given
sequence during the treatment (Activity Coded 0,
Activity Coded 1, Activity Coded 2 representing
Activity (sequence number) are among the most
important features for predicting the cancer.
Estimators Maximum features Accuracy
1000 100 0.556
1500 200 0.572
TABLE III
RESULTS OBTAINED WHILE CONDUCTING A CROSS VALIDATION
GRID SEARCH OVER THE THE NUMBER OF ESTIMATORS AND SIZE
OF THE RANDOM SUBSETS OF FEATURES USED FOR SPLITTING A
NODE IN THE TREE.
Fig. 11. Top 5 important features used by Random Forest
classifier.
The importance of a feature when using a Ran-
dom forest classifier is computed using the ‘gini
impurity’ measure that indicates the effectiveness
of a feature in reducing uncertainty when creating
decision trees. However, this method tends to inflate
the importance of continuous or high-cardinality
categorical variables [49]. Hence, while feature im-
portance using ‘gini impurity’ measure has been
consistently used, it is provides interpretability of the
entire model and does not provide explanation of a
specific instance.
D. From Predictability to Explanability using LIME
LIME [19] is used to explain a single prediction
as well a global explanation of the model using
a subset of individual data points or instances.
LIME approximates the underlying model by an
interpretable model such as a linear model that
is learned on small perturbations of the original
data point. This is done by weighting the perturbed
instance by their similarity to the instance to be
explained. Hence, the explanations are based on
a linear model in the neighborhood of the instance
and the explanations for an instance does not rep-
resent how the model behaves for all data points
or cancer patients. Figure 12 illustrates the local
Fig. 12. Local interpretation of 106 cancer class for a patient.
explanations of predicting the cancer class ‘106’
which is associated to cervix, vulva, corpus uteri
and vagina. The explanations are based on the
features Age > 70, and specific activities performed
at a given step or sequence during the treatment (
Activity_(sequence_number) ).
The global understanding of the model is provided
by explaining a set of individual instances. The
global explanations of the model are constructed
by picking a subset of instances and their expla-
nations. The importance of a feature in an expla-
nation and the coverage of all features defines a
coverage function that is maximized to pick a sub-
set of instances and generate global explanations.
Figure 13 presents the global explanation for the
cancer class ‘106’. Here the age, the treatment and
activities performed initially provide explanation of
the predictions. Global explanations for two cancer
classes (M11, M14) are presented in Figure 14 and
Figure 15 respectively. While some of the features
used by the model are relevant such as Age and
the treatment undertaken, many features such as
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Fig. 13. Global interpretation of class 106 cancer.
the activity ‘Consultation’, or being associated to
the ‘Obstetrics & Gynaecology clinic’ are not signif-
icantly distinct features and cannot be generalized
in predicting the type of cancer. However, use of
Fig. 14. Global interpretation of class M11 cancer.
such explanations provides good insight into the
model and improves the trust in the prediction, and
the features used for the prediction. In the context
of traditional machine learning algorithms, use of
local explanations provide insights on the design of
features.
VI. CONCLUSIONS
In this work, we explored the usage of deep learn-
ing techniques and random forests in a real world
Fig. 15. Global interpretation of class M14 cancer.
medical event log from a hospital in the Netherlands
containing the track of medical records undertaken
by patients with cancer. Our hypothesis was that, in
theory, patients with a specific type of cancer should
be associated to a more targeted set of medical
activities that are particular to their type of cancer.
Results showed significant results and that one
could actually predict the type of cancer given past
medical records of patients. The structured learning
models that we explored learnt to fuse different
modalities of information, based not only on the
patients’ track of medical activities, but also other
features such as age, time spent in treatment, etc.
This fusion of information is non-linear and leads
to the representation of one single non-linear state
of knowledge. However, this analysis in terms of
accuracies can be misleading since we do not have
any understandings of how the learning algorithms
were making the classification.
In this sense, this paper also explored explanabil-
ity and interpretability techniques in the scope of
medical event logs. In order to gain more insights
about the model’s black box, we intercepted the
hidden layers of deep neural networks with au-
toencoders in order to learn a generalized latent
space that better approximates to the training data.
From the structured deep learning network, the
autoenconders apply a non-linear transformation in
the data that leads to a non-linear representation
of clusters that can be helpful to provide additional
insights and that can enable the investigation of mis-
classifications in the dataset. This method provided
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better insights of why the algorithm is classifying
the data correctly or incorrectly, and provided new
understandings to the decision-maker.
For random forests, we explored local surro-
gate models, more specifically the local inter-
pretable model-agnostic explanations (LIME) frame-
work. LIME is a metamodel that instead of interpret-
ing directly the black box, it uses the metamodel
to draw conclusions and interpretations about the
black box. The individual predictions were computed
by applying perturbations of the points in the original
dataset. This allows one to see how the features
change around these points and how they affect
the predictions. Results indicate that learning an
interpretable model locally around the model’s pre-
diction leads to a higher understanding about why
the algorithm is making some decision. The use of
local and linear model helped to identify the features
used during the cancer prediction of an individual
patient. We were able to identify distinct features
used in different predictions, along with features that
do not generalize or are not relevant.
In summary, both methods provided different sub-
symbolic interpretation insights, one based on non-
linear cluster representations (autoecoders) and the
other based on the local impact of features in indi-
vidual points in the data (LIME).
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